Related Experiment Videos
The evolving treatment of dry eye
1Eye and Ear Institute, Department of Ophthalmology, University of Pittsburgh School of Medicine, 203 Lothrop Street, Pittsburgh, PA 15213, USA. foulksgn@msx.upmc.edu
Ophthalmology Clinics of North America
|April 10, 2003
Summary
Current dry eye disease treatments focus on symptom relief and tear preservation. New therapies targeting inflammation and hormonal balance, including P2Y2 agonists, are nearing approval for underlying causes.
Area of Science:
- Ophthalmology
- Dry Eye Disease Research
Background:
- Palliative treatments remain crucial for dry eye disease management.
- Existing therapies focus on tear supplementation and preservation.
Purpose of the Study:
- To review current and emerging therapeutic strategies for dry eye disease.
- To highlight advancements in understanding and treating the underlying causes of dry eye.
Main Methods:
- Review of historical and current palliative treatments for dry eye.
- Discussion of novel approaches including P2Y2 agonists and immunomodulation.
- Exploration of strategies to restore ocular surface-lacrimal gland homeostasis.
Main Results:
- Palliative treatments continue to evolve and are effective for symptom management.
- P2Y2 agonists show promise for tear stimulation.
- Immunomodulatory and hormonal balancing strategies are emerging to address disease mechanisms.
Conclusions:
- Significant progress has been made in understanding dry eye disease pathogenesis.
- Novel treatments targeting the root causes of dry eye are anticipated within the next three years.